Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
As we noted in our previous analysis (attached to the chart), CNXU stock has now officially managed to break out of its consolidation structure and appears to be moving into the next phase of its move. ⚠️
After the volatile Nasdaq debut and post-IPO correction, buyers were able to reclaim the upper end of their accumulation range, indicating that momentum was starting to shift in favor of the bulls. 📈
📊Technically, this kind of breakout is important because newly listed stocks usually go through a clear structural phase in the market:
• Initial price discovery phase
• Correction after insertion
• Assembly stage
• Price increase phase (uptrend)
It seems that CNXU is now entering the price increase stage.
📈As long as buyers maintain control above the early rally area, we will continue to look for buying opportunities on every pullback.
Because CNXU is still a newly listed stock, historical price data is limited, and traditional resistance areas remain relatively unclear.
Therefore, during the price discovery phase, round psychological numbers become even more important.
🎯Goal:
• First Bullish Target: $15
• Second bullish target: $20
• Thereafter, if momentum continues to accelerate, the price discovery movement will remain largely open. 🚀
📰Fundamentally, CNXU continues to attract speculative attention due to its focus on regenerative medicine and 3D bioprinting technology.
The company recently launched the BREAST™ platform for biological tissue reconstruction, which aims to shift the reconstruction process from traditional implant reliance to biologically assisted tissue regeneration. 🧬
In short, CNXU appears to be moving from a consolidation phase to a markup as new price discovery conditions continue to support accelerating momentum.
⚠️Disclaimer: This is not financial advice. Always conduct your own research and properly manage risks.
📚Stick to your trading plan in terms of entry, risk and management.